Article
Immunohistochemistry-based taxonomical classification of bladder cancer predicts response to neoadjuvant chemotherapy
2019-08-05
Abstract excerpt
<h4>ABSTRACT</h4> Platinum-based neoadjuvant chemotherapy (NAC) increases the survival of patients with organ-confined urothelial bladder cancer (UBC). Because not all patients benefit from treatment, NAC has not been widely applied in the clinical setting. There is strong evidence, based on retrospective studies, that patients with Basal/Squamous (BASQ)-like tumours present with more advanced disease and have wo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2d07bf1a-31ea-5f4e-a705-ba41656ee515
- DOI
- 10.1101/724351
